AMP
61
-2
NRG
82
2
L
51
2
IVZ
46
-2
XRX
23
-9
LH
52
12
CVX
28
2
CCI
30
2
MO
57
3
MAC
47
-3
UPS
33
-2
GME
94
3
ECL
50
3
DE
46
-3
STZ
30
-3
ACN
47
-5
DVN
27
2
GM
69
-3
CTSH
52
-2
A
44
-2
AMP
61
-2
NRG
82
2
L
51
2
IVZ
46
-2
XRX
23
-9
LH
52
12
CVX
28
2
CCI
30
2
MO
57
3
MAC
47
-3
UPS
33
-2
GME
94
3
ECL
50
3
DE
46
-3
STZ
30
-3
ACN
47
-5
DVN
27
2
GM
69
-3
CTSH
52
-2
A
44
-2
Financhill
Back

Invesco Biotechnology & Genome ETF Stock Predictions

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
38

PBE
Invesco Biotechnology & Genome ETF

Last Price:
$61.73
Seasonality Move:
4.95%

7 Day Trial

ALL ACCESS PASS

$ 7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio

Invesco Biotechnology & Genome ETF Stock Forecast

  • Over the next 52 weeks, Invesco Biotechnology & Genome ETF has on average historically risen by 9.8% based on the past 19 years of stock performance.
  • Invesco Biotechnology & Genome ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is Invesco Biotechnology & Genome ETF Stock Undervalued?
    The current Invesco Biotechnology & Genome ETF [PBE] share price is $61.73. The Score for PBE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PBE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Invesco Biotechnology & Genome ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Invesco Biotechnology & Genome ETF has on average historically risen by 9.8% based on the past 19 years of stock performance.

Invesco Biotechnology & Genome ETF Stock Rating

Sell
38
Invesco Biotechnology & Genome ETF (PBE) is a Sell

Is Invesco Biotechnology & Genome ETF overpriced?

  • Invesco Biotechnology & Genome ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

Invesco Biotechnology & Genome ETF Stock Price History

Is PBE stock going to rise?

  • The current trend is relatively stagnant and PBE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
72.84
52-Week Low:
54.52

Prediction Charts

Market Cap:
0
Price in USD:
61.73
Volume:
3.9K
Beta:
0.94

Technical Analysis

SMA50:
61.79
SMA100:
64.74
SMA200:
67.07
52-Wk Change:
-3.5%

Stock Predictions

  • Is Invesco Biotechnology & Genome ETF stock public?
    Yes, Invesco Biotechnology & Genome ETF is a publicly traded company.
  • What is the Invesco Biotechnology & Genome ETF stock quote today?
    The Invesco Biotechnology & Genome ETF stock price is 61.73 USD today.
  • How to buy Invesco Biotechnology & Genome ETF stock online?
    You can buy Invesco Biotechnology & Genome ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 61.81 59.89 61.82 59.77
May-7 60.11 60.33 60.39 59.63
May-8 60.12 60.48 60.81 59.01
May-9 60.99 59.58 60.99 59.58
May-12 60.73 62.05 62.23 60.73
May-13 60.60 60.52 60.73 60.35
May-14 60.85 59.87 60.98 59.83
May-15 59.98 60.84 60.90 59.75
May-16 61.08 62.31 62.38 60.83
May-19 61.97 62.83 62.83 61.97
May-20 62.65 63.34 63.44 62.45
May-21 62.45 61.95 62.69 61.95
May-22 61.76 61.70 61.89 61.40
May-23 60.87 61.73 61.95 60.87

Invesco Biotechnology & Genome ETF Earnings

Data Unavailable

Invesco Biotechnology & Genome ETF Forecast Revenue Growth

Data Unavailable

* Invesco Biotechnology & Genome ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.